RPN1 promotes the proliferation and invasion of breast cancer cells by activating the PI3K/AKT/mTOR signaling pathway

被引:0
作者
Wei-juan Shen
Yi Zhang
机构
[1] Changzhou Wujin People’s Hospital (Wujin Hospital Affiliated with Jiangsu University),Department of Breast surgery
[2] The Wujin Clincal college of Xuzhou Medical University,Department of Breast surgery
来源
Discover Oncology | / 15卷
关键词
RPN1; Breast cancer; PI3K/AKT/mTOR; Migration; Invasion;
D O I
暂无
中图分类号
学科分类号
摘要
Ribophorin I (RPN1), a part of an N-oligosaccharyl-transferase complex, plays a vital role in the development of multiple cancers. However, its biological role in breast cancer has not been completely clarified. The RPN1 expression level was measured in breast cancer tissues and breast cancer cell lines (MCF7) using RT-qPCR. After down-regulating RPN1 expression by shRNA, the effects of RPN1 on the proliferation, migration and invasion of MCF7 cells were examined. Mechanistically, we assessed the effect of RPN1 on the PI3K/ AKT/mTOR signaling pathway. We found that RPN1 level was up-regulated in breast cancer tissues and cells compared with adjacent non-tumor tissues or MCF10A cells. RPN1 knockdown induced apoptosis and attenuated the proliferation, migration, and invasion of MCF7 cells. Moreover, RPN1 knockdown lowered the levels of p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR, which were rescued by 740Y-P, a PI3K activator. 740Y-P also reversed the effects of RPN1 knockdown on apoptosis, proliferation, migration, and invasion in MCF7 cells. Taken together, RPN1 promotes the proliferation, migration, and invasion of breast cancer cells via the PI3K/AKT/mTOR signaling pathway.
引用
收藏
相关论文
共 171 条
[1]  
Azamjah N(2019)Global trend of breast cancer mortality rate: a 25-year study Asian Pac J Cancer Prev 20 2015-2020
[2]  
Soltan-Zadeh Y(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30
[3]  
Zayeri F(2022)Breast cancer metastasis: mechanisms and therapeutic implications Int J Mol Sci 23 13-26
[4]  
Siegel RL(2021)The lingering mysteries of metastatic recurrence in breast cancer Br J Cancer 124 77-106
[5]  
Miller KD(2018)Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis Genes Dis 5 280-284
[6]  
Park M(2021)Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment Strategies—an updated Rev Cancers (Basel). 6C 487-788
[7]  
Kim D(2015)A case of long term survival with skeletal only metastatic breast cancer Int J Surg Case Rep 12 779-38089
[8]  
Ko S(2022)Glycotherapy. A new paradigm in breast cancer research Biomolecules. 46 38080-9539
[9]  
Kim A(2018)O-linked mucin-type glycosylation in breast cancer Biochem Soc Trans 11 9534-3060
[10]  
Mo K(2021)Knockdown of oligosaccharyltransferase subunit ribophorin 1 induces endoplasmic-reticulum-stress-dependent cell apoptosis in breast cancer Front Oncol 287 3050-4417